. 2018 Dec 6;6(15):995–1006. doi: 10.12998/wjcc.v6.i15.995

Table 1.

The characteristics of studies included in the meta-analysis

Study	Country	Study design	Sex (M/F)	Age (yr)	Number of patients	End-point of observation	Scoring system	Etiology
Radisavljevic et al[20], 2017	Peru	p	79/8	54	87	29 mo	CTP, MESO, MELD	Alcohol
Iino et al[21], 2017	Japan	r	39/8	60	47	1.5 mo	CTP, MELD	HBV, HCV, Alcohol, Others
Barosa et al[22], 2017	Portugal	r	Unknown	62	49	1, 3 mo	CTP, MELD, MELD-Na	Alcohol, HCV
Cheng et al[23], 2016	China	p	87/12	48	98	1, 3, 6, 12 mo	CTP, MELD, MELD-Na	HBV
Bal et al[24], 2016	India	r	177/41	50	218	1.6 mo	MELD-Na	Ethanol, Crypto/NAFLD,HCV
Silva et al[25], 2015	Brazil	p	140/52	54	192	1 mo	MELD, CTP	Alcohol, HBV, HCV, Cryptogenic, Others
Silva et al[25], 2015	Brazil	p	140/52	54	189	3 mo	MELD, CTP	Alcohol, HBV, HCV, Cryptogenic, Others
Fayad et al[26], 2015	Brazil	p	94/29	54	123	In hospital	MELD, MELD-Na, MESO	HBV, HCV, Alcohol, Cryptogenic, Others
Suk et al[27], 2012	Korea	p	46/11	48	57	36 mo	MELD, MELD-Na	Alcohol, Viral, Alcohol + Viral
Li et al[28], 2012	China	r	133/79	56	212	3, 6, 12 mo	MELD, MELD-Na, MESO	HBV, HCV, Alcohol, Primary biliary cirrhosis, Other
Shaikh et al[29], 2010	India	p	72/38	47	110	In hospital	MELD, CTP	HBV, HCV
Boursier et al[30], 2009	France	p	93/61	59	154	6 mo	CTP, MELD, MELD-Na	Alcohol, Viral, Others
Hyun et al[31], 2012	Korea	r	63/23	54	83	6 mo	CTP	HBV
Peng et al[32], 2015	China	r	94/51	57	145	In hospital	MELD, CTP	HBV, HCV, Alcohol, Unknown, Others
Sempere et al[33], 2009	Spain	r	142/59	59	201	1.5, 3, 12, 36 mo	MELD, CTP	Alcohol, Viral, Others
Teng et al[34], 2014	China	r	110/22	51	132	1.5 mo	MELD, CTP	Alcohol, HBV, HCV,
Wang et al[35], 2014	China	p	340/89	49	429	3, 12 mo	CTP, MELD-, MELA-Na	HCV, HBV, Alcohol, Biliary, Others

P: Prospectively study; r: Retrospectively study; CTP: Child-Turcotte-Pugh; MELD: Model for End-stage Liver Disease score; MESO: MELD to Serum Sodium ratio; HBV: Hepatitis B virus; HCV: Hepatitis C virus; NAFLD: Nonalcoholic fatty liver disease.